Koers SciClone Pharmaceuticals, Inc.

Aandelen

13-10-17	SciClone Pharmaceuticals : Consortium Led By GL Capital Completes Acquisition Of SciClone
29-08-17	Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017
16-08-17	SciClone Pharmaceuticals : Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma
10-08-17	SciClone Pharmaceuticals : Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties
09-08-17	SciClone Pharmaceuticals : Reports Second Quarter 2017 Financial Results

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
SCICLONE PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	+0,88%	+6,38%	+76,40%	+126,87%	1.119 mld.
JOHNSON & JOHNSON	+1,07%	+3,80%	+50,73%	+64,25%	651 mld.
ABBVIE INC.	+1,20%	+6,21%	+25,81%	+80,15%	468 mld.
ROCHE HOLDING AG	-1,64%	+3,76%	+42,17%	+42,03%	374 mld.
NOVARTIS AG	-0,91%	+2,19%	+24,56%	+40,33%	302 mld.
ASTRAZENECA PLC	-1,32%	+4,31%	+1,57%	+12,17%	259 mld.
AMGEN INC.	+1,29%	+5,81%	+49,57%	+70,71%	238 mld.
NOVO NORDISK A/S	+0,56%	+3,57%	-17,55%	-53,10%	208 mld.
GILEAD SCIENCES, INC.	+1,87%	+5,61%	+27,32%	+89,67%	181 mld.
Gemiddelde	+0,24%	+5,17%	+31,17%	+52,56%	422,21 mld.
Gewogen gemiddelde per kap.	+0,33%	+5,40%	+44,02%	+72,21%

Werknemers

Sector